← Human Trials & Peer-Reviewed Studies
The Combination of Non-dipper Heart Rate and High Brain Natriuretic Peptide Predicts Cardiovascular Events: The Japan Morning Surge-Home Blood Pressure (J-HOP) Study
Plain-language guide to PMID 32090237 (2020): observational study of BNP (Nesiritide) in 1,369 patients, low blood pressure and orthostatic hypotension.
Key Facts
- PMID
- 32090237
- Journal
- American journal of hypertension
- Year
- 2020
- Study type
- Observational Study
- Authors
- Ogoyama Y et al. (4 authors)
- DOI
- 10.1093/ajh/hpaa025
What This Study Did, in Plain Language
What Was Tested
This observational study looks at BNP (Nesiritide) in the context of low blood pressure and orthostatic hypotension.
The researchers hypothesized that the association between the dipping heart rate (HR) pattern and cardiovascular (CV) events differs according to the brain natriuretic peptide (BNP) level.
Who Took Part
According to the abstract, 1,369 patients were involved.
The age groups tagged for this paper are middle-aged adults, older adults and people over 80, both men and women.
The researchers examined a subgroup of 1,369 patients from the Japan Morning Surge Home Blood Pressure study; these were patients who had CV risk factors and had undergone ambulatory blood pressure (BP) monitoring.
The researchers divided the patients into four groups according to their HR dipper status (dipping or non-dipping) and BNP level (normal or high).
How the Study Was Run
HR non-dipping status was defined as (awake HR - sleep HR)/awake HR <0.1, and high BNP was defined as ≥35 pg/ml.
What Was Measured
The researchers hypothesized that the association between the dipping heart rate (HR) pattern and cardiovascular (CV) events differs according to the brain natriuretic peptide (BNP) level.
The subject headings attached to it are Biomarkers, Blood Pressure, Cardiovascular Diseases, Circadian Rhythm, Heart Disease Risk Factors, Heart Rate and Hypertension.
The authors tagged it with the keywords brain natriuretic peptide, cardiovascular event and non-dipper heart rate.
What This Means in Plain Language
This is an observational study of BNP (Nesiritide) in 1,369 patients in people with low blood pressure and orthostatic hypotension.
With several hundred people or more, it is a fairly large study for this kind of research.
Its findings take up roughly 5 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 2020 (American journal of hypertension), a journal based in United States.
More context: the BNP (Nesiritide) compound page, Low blood pressure and orthostatic hypotension research.
Our Notes on the Compound
BNP (Nesiritide): B-type natriuretic peptide, a 32-amino-acid heart hormone; nesiritide (Natrecor) is a recombinant form used in acute heart failure.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.